New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
10:00 EDTUCBI, HAE, BPI, BKE, SWY, OCR, CPA, SIRI, PRU, SD, UNP, TEVA, QSII, GTAT, IVN, CLH, CHTR, BMO, TFM, SKUL, PLCM, CCRN, COGOn The Fly: Analyst Upgrade Summary
Copa Holdings (CPA) upgraded to Buy from Neutral at UBS... Cross Country Healthcare (CCRN) upgraded to Buy from Neutral at Citigroup... GT Advanced (GTAT) upgraded to Outperform from Neutral at Credit Suisse... Omnicare (OCR) upgraded to Buy from Neutral at UBS... Polycom (PLCM) upgraded to Buy from Neutral at Citigroup... Quality Systems (QSII) upgraded to Market Perform from Underperform at FBR Capital... Safeway (SWY) upgraded to Neutral from Sell at UBS... Skullcandy (SKUL) upgraded to Outperform from Market Perform at Northland Securities... Teva (TEVA) upgraded to Overweight from Equal Weight at Barclays... The Buckle (BKE) upgraded to Neutral from Sell at Janney Capital... The Fresh Market (TFM) upgraded to Buy from Neutral at UBS... Union Pacific (UNP) upgraded to Outperform from Market Perform at Avondale... Bridgepoint Education (BPI) upgraded to Outperform at William Blair... Bank of Montreal (BMO) upgraded to Sector Performer from Underperformer at CIBC... SandRidge Energy (SD) upgraded to Overweight at Stephens citing turnaround progress... Haemonetics (HAE) upgraded to Buy from Neutral at Sidoti... Charter (CHTR) upgraded at Northland Securities... Prudential (PRU) upgraded to Buy from Neutral at BofA/Merrill... United Community Banks (UCBI) upgraded to Buy from Hold at Sandler O'Neill... Sirius XM (SIRI) upgraded at Macquarie... Clean Harbors (CLH) upgraded at Raymond James... Cabot Oil & Gas (COG) upgraded to Buy from Accumulate at KLR Group... Ivanhoe Mines (IVN) upgraded to Buy from Neutral at UBS.
News For CPA;CCRN;GTAT;OCR;PLCM;QSII;SWY;SKUL;TEVA;BKE;TFM;UNP;BPI;BMO;SD;HAE;CHTR;PRU;UCBI;CLH;SIRI;COG;IVN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
January 21, 2015
13:36 EDTUCBIUnited Community upgraded to Outperform from Market Perform at Fig Partners
Subscribe for More Information
08:38 EDTTEVAMomenta announces Supreme Court decision to remand generic Copaxone back to CAFC
Subscribe for More Information
05:34 EDTUCBIUnited Community Banks reports Q4 EPS 30c, consensus 30c
Subscribe for More Information
January 20, 2015
14:37 EDTTEVATeva generic competition to Copaxone pushed out by ruling, says BMO Capital
Subscribe for More Information
12:56 EDTTEVAMylan says continues to believe '808 patent is 'invalid'
Subscribe for More Information
11:29 EDTTEVATeva says Supreme Court reverses circuit court judgment on Copaxone 20 mg/mL
Teva Pharmaceutical announced the U.S. Supreme Court’s decision in Teva Pharmaceuticals USA, Inc. et al. Petitioners v. Sandoz Inc. et al. that reversed the Federal Circuit Court’s judgment of invalidity of Teva’s ‘808 patent for COPAXONE 20 mg/mL. The Supreme Court remanded the case to the Federal Circuit for further review in light of the applicable standard the Supreme Court laid out for appellate review of claim construction. A ruling last year by the U.S. Court of Appeals for the Federal Circuit upheld four Teva patents that expired in May 2014, while invalidating the ‘808 patent that is set to expire on September 1, 2015. “We are encouraged by the U.S. Supreme Court’s Decision and look forward to the Federal Circuit’s review. We will continue to explore all available avenues to protect our intellectual property for COPAXONE 20mg/mL,” said Erez Vigodman, President and CEO of Teva. “There is currently no FDA-approved follow-on version of Teva’s COPAXONE. We are encouraged by the FDA’s willingness to date to have dialogue regarding the complexities of COPAXONE 20 mg/mL and the potential limitations and other unknowns of purported follow-on versions,” added Rob Koremans, MD, President and CEO of Global Specialty Medicines at Teva.
10:45 EDTTEVATeva spikes, retraces, after win in Copaxone patent case
Subscribe for More Information
10:40 EDTTEVAMomenta Pharma sinks after Supreme Court rules on Copaxone
Subscribe for More Information
10:35 EDTTEVATeva rises after patent ruling upheld by Supreme Court
The Supreme Court upheld a lower court ruling related to generic versions of Teva's Copaxone drug. In the ruling, the court wrote that "When reviewing a district court’s resolution of subsidiary factual matters made in the course of its construction of a patent claim, the Federal Circuit must apply a “clear error,” not a de novo, standard of review." Teva shares are up 1.5% to $58.58 in early trading after the ruling. Reference Link
07:45 EDTCLHClean Harbors to host business news update conference call
Subscribe for More Information
07:43 EDTUNPUnion Pacific weakness creates opportunity, says Bernstein
Subscribe for More Information
07:33 EDTCLHClean Harbors sees FY15 adjusted EBITDA $530M-$570M
Subscribe for More Information
07:32 EDTCLHClean Harbors sees FY14 revenue $3.4B-$3.42B, consensus $3.4B
Subscribe for More Information
07:32 EDTCLHClean Harbors confirms FY14 revenue, adjusted EBITDa guidance
Subscribe for More Information
07:31 EDTCLHClean Harbors to spin out Oil and Gas Field Services as standalone entity
Clean Harbors announced that, as a result of its strategic review, the company plans to carve out its Oil and Gas Field Services segment as a standalone public entity. Due to the synergies related to drilling activity, Clean Harbors also intends to include its lodging drill camps business from its Lodging segment as part of the new entity. “During the fourth quarter, we completed the comprehensive strategic review of our portfolio that we began in early 2014,” said Alan S. McKim, chairman and CEO. “The review was designed to determine the optimal mix of businesses to drive organic growth, enhance our margins and improve our return on invested capital. Based on this review, we are undertaking a number of initiatives to maximize shareholder value, including the carve-out of our Oil and Gas Field Services segment, while retaining the vast majority of our Lodging segment and our re-refining business.” Since acquiring many of the Oil and Gas segment’s assets in 2009, Clean Harbors has significantly grown the business and greatly expanded the value proposition it offers customers to encompass a combination of exploration, seismic and drilling support, solids/fluids control packages, disposal of drill cuttings and production services. Including the lodging drill camps business, the assets the Company plans to carve out generated approximately $250M in revenue through the first nine months of 2014. While the Oil and Gas Field Services segment experienced a down cycle in the past year, the company believes it constitutes an attractive long-term cyclical business that is well-positioned as a leader within many markets. Clean Harbors has hired Goldman Sachs & Co. as its financial advisor to assist in the proposed transaction, a process that could take more than 12 months. Completion of the transaction is subject to certain conditions, including, but not limited to, determination of the most advantageous structure from a financial and tax standpoint, receipt of regulatory approvals, the effectiveness of securities laws filings and final approval by the company’s Board of Directors. There can be no assurance regarding the ultimate structure and timing of the proposed transaction or whether the transaction will be completed.
07:31 EDTCLHClean Harbors names Eric Gerstenberg as COO
Subscribe for More Information
07:31 EDTSDSandRidge Energy upgraded to Hold from Reduce at KLR Group
Subscribe for More Information
07:30 EDTCLHClean Harbors to spin out Oil and Gas Field Services as standalone entity
Subscribe for More Information
06:28 EDTCPACopa Holdings upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded Copa Holdings to Overweight saying the company is likely to revise upward its 2015 guidance to reflect lower fuel prices. The firm finds the stock's valuation attractive and raised its price target for shares to $130 from $120.
06:09 EDTIVNIvanhoe Mines downgraded to Neutral from Buy at BofA/Merrill
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use